Medical Dialogues7h
Bristol Myers Squibb receives positive EMA Committee opinion for Perioperative Opdivo plus Chemo in Resectable Non-Small Cell Lung Cancer plus PD-L1
Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...
Teacher Retirement System of Texas Raises Position in Nuvalent, Inc. (NASDAQ:NUVL)
Teacher Retirement System of Texas lifted its stake in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 43.1% during the fourth quarter, according to its most recent disclosure with the ...
Why Nuvalent (NUVL) Is Among the Best Mid Cap Biotech Stocks to Buy
We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...
European Medical Journal23h
Minimal Residual Disease May Predict NSCLC Recurrence After Osimertinib
Molecular residual disease detection may help identify patients with EGFR-mutated NSCLC who could benefit from prolonged ...
Knowridge Science Report23h
Blood test may help predict lung cancer recurrence, Yale study finds
In the growing field of personalized medicine, scientists at Yale University have found promising evidence that a simple ...
The American Journal of Managed Care20h
Ticagrelor Antidote Bentracimab Safely Reverses Antiplatelet Effects in Phase 3 REVERSE-IT Trial
Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.
New sickle cell treatment could cure thousands in Louisiana
Kelsi Victorian, 30, has been in and out of the hospital her whole life dealing with a disease that affects millions in the world.